Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Parsons

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Plos One|October 24, 2018
Cost-effectiveness of targeted thrombolytic therapy for stroke patients using multi-modal CT compared to usual practicePenny Reeves, Kim Edmunds, Christopher Levi, et al.
The Lancet. Neurology|July 30, 2010
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTRNiaz Ahmed, Nils Wahlgren, Martin Grond, et al.
CNS Neuroscience & Therapeutics|November 13, 2023
Asymmetric deep cerebral venous filling predicts poor outcome of acute basilar artery occlusion after endovascular treatmentHuiyuan Wang, Panpan Shen, Xinyue Yu, et al.
BMJ Neurology Open|March 6, 2026
Predicting cancer aetiology in patients with stroke using brain imaging aloneShyam Gangadharan, Christopher Levi, Mark Parsons, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 2, 2016
International benchmarking for acute thrombolytic therapy implementation in Australia and JapanHiroyuki Kawano, Christopher Levi, Yuichiro Inatomi, et al.
Stroke and Vascular Neurology|May 29, 2023
Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trialYunyun Xiong, Bruce C V Campbell, Marc Fisher, et al.
Frontiers in Neurology|September 27, 2021
Assessing the Relative Value of CT Perfusion Compared to Non-contrast CT and CT Angiography in Prognosticating Reperfusion-Eligible Acute Ischemic Stroke PatientsAndrew Bivard, Christopher Levi, Longting Lin, et al.
Frontiers in Medical Technology|April 6, 2023
A descriptive study of the clinical impacts on COVID-19 survivors using telemonitoring (The TeleCOVID Study)Josephine Sau Fan Chow, Annamarie D'Souza, Megan Ford, et al.
Frontiers in Neurology|September 22, 2018
Growth Hormone Deficiency Is Frequent After Recent StrokeThomas Lillicrap, Carlos Garcia-Esperon, Frederick Rohan Walker, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 20, 2024
Large vessel occlusive stroke with milder baseline severity shows better collaterals and reduced harm from thrombectomy transfer delaysHannah Rowling, Dominic Italiano, Leonid Churilov, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Plos One|October 24, 2018
Cost-effectiveness of targeted thrombolytic therapy for stroke patients using multi-modal CT compared to usual practicePenny Reeves, Kim Edmunds, Christopher Levi, et al.
The Lancet. Neurology|July 30, 2010
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTRNiaz Ahmed, Nils Wahlgren, Martin Grond, et al.
CNS Neuroscience & Therapeutics|November 13, 2023
Asymmetric deep cerebral venous filling predicts poor outcome of acute basilar artery occlusion after endovascular treatmentHuiyuan Wang, Panpan Shen, Xinyue Yu, et al.
BMJ Neurology Open|March 6, 2026
Predicting cancer aetiology in patients with stroke using brain imaging aloneShyam Gangadharan, Christopher Levi, Mark Parsons, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 2, 2016
International benchmarking for acute thrombolytic therapy implementation in Australia and JapanHiroyuki Kawano, Christopher Levi, Yuichiro Inatomi, et al.
Stroke and Vascular Neurology|May 29, 2023
Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trialYunyun Xiong, Bruce C V Campbell, Marc Fisher, et al.
Frontiers in Neurology|September 27, 2021
Assessing the Relative Value of CT Perfusion Compared to Non-contrast CT and CT Angiography in Prognosticating Reperfusion-Eligible Acute Ischemic Stroke PatientsAndrew Bivard, Christopher Levi, Longting Lin, et al.
Frontiers in Medical Technology|April 6, 2023
A descriptive study of the clinical impacts on COVID-19 survivors using telemonitoring (The TeleCOVID Study)Josephine Sau Fan Chow, Annamarie D'Souza, Megan Ford, et al.
Frontiers in Neurology|September 22, 2018
Growth Hormone Deficiency Is Frequent After Recent StrokeThomas Lillicrap, Carlos Garcia-Esperon, Frederick Rohan Walker, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 20, 2024
Large vessel occlusive stroke with milder baseline severity shows better collaterals and reduced harm from thrombectomy transfer delaysHannah Rowling, Dominic Italiano, Leonid Churilov, et al.
Pageof 18